DiscoverX KINOMEscan® Kinase Assay Screening
The most comprehensive kinase inhibitor screening panel with over 480 kinase assays to screen against on a single technology platform…
KINOMEscan enables you to quantitatively measure interactions between test compounds and more than 480 kinase assays including clinically relevant mutants, lipid, atypical, and pathogen kinases, plus a growing panel of activation-state specific assays. The KINOMEscan platform utilizes a novel active site-directed competition binding assay to provide robust and informative binding data.
Downloads
Learn More
Click here to find out more via email
Related content from this organisation
Related topics
Assays, Drug Discovery Processes, Screening
Related organisations
DiscoverX Corporation
